U.S. markets closed
  • S&P Futures

    3,450.25
    +18.00 (+0.52%)
     
  • Dow Futures

    28,316.00
    +134.00 (+0.48%)
     
  • Nasdaq Futures

    11,722.75
    +62.00 (+0.53%)
     
  • Russell 2000 Futures

    1,625.30
    +10.50 (+0.65%)
     
  • Crude Oil

    41.55
    -0.15 (-0.36%)
     
  • Gold

    1,922.10
    +6.70 (+0.35%)
     
  • Silver

    25.17
    +0.19 (+0.74%)
     
  • EUR/USD

    1.1848
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    0.7970
    +0.0360 (+4.73%)
     
  • Vix

    29.35
    +0.17 (+0.58%)
     
  • GBP/USD

    1.2974
    +0.0028 (+0.21%)
     
  • USD/JPY

    105.3630
    -0.1070 (-0.10%)
     
  • BTC-USD

    12,211.22
    +1,154.22 (+10.44%)
     
  • CMC Crypto 200

    244.87
    +5.96 (+2.49%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,676.90
    +109.86 (+0.47%)
     

OtoNexus Medical Technologies at the Forefront of Providing Infection Control Solution

·2 mins read

MedTech Outlook Selects OtoNexus as a Top Infection Control Solution Provider for 2020

SEATTLE, Oct. 1, 2020 /PRNewswire/ -- OtoNexus Medical Technologies Inc. announced today that MedTech Outlook selected OtoNexus as one of 10 companies nationwide as companies that are at the forefront of providing infection control solutions and having an impact on the industry.

MedTech Outlook Selects OtoNexus as a Top Infection Control Solution Provider for 2020
MedTech Outlook Selects OtoNexus as a Top Infection Control Solution Provider for 2020

OtoNexus has developed the world's first ultrasound hand-held device to evaluate the four disease states of middle ear infection. With the tools available today, detection accuracy is approximately 50% in the critical differentiation of viral versus bacterial infections. As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children.

The Center for Disease Control suggests prescribing antibiotics for about 15% of middle ear infections. However, antibiotics are prescribed nearly 85% of the time. "Our goal is to decrease the usage of antibiotic therapy by 50% for the treatment of middle ear infections," said Caitlin Cameron, CEO OtoNexus Medical Technologies. It is an honor that MedTech Outlook recognizes how our unique technology empowers physicians to avoid unnecessary prescriptions of antibiotics and improve treatment of middle ear infections."

The OtoNexus device has the potential to:

  • Minimize the use of unnecessary antibiotics in the treatment of middle ear infections

  • Improve patient outcomes with timely, accurate diagnosis and treatment

  • Reduce the cost of care by decreasing the number of follow up visits due to adverse antibiotics side effects and referrals to specialists

"We have been quite impressed by OtoNexus Medical Technologies' expertise in providing infection control solutions," said Alex D' Souza, Managing Editor of MedTech Outlook magazine." We congratulate OtoNexus Medical Technologies on this prestigious recognition and look forward to seeing their impressive growth streak continue."

To learn more, read the full article at MedTech Outlook.

About OtoNexus Medical Technologies Inc.

OtoNexus has developed the world's first hand-held medical device with miniaturized ultrasound technology to instantly and accurately diagnose middle ear infections. In less than 2 seconds, physicians can evaluate middle ear infections and know whether antibiotic therapy is appropriate. This definitive test will provide physicians the information they need to minimize the use of antibiotics, improve patient outcomes, and reduce the cost of care. For more information, please visit www.otonexus.com

About MedTech Outlook

MedTech Outlook is a platform that bridges the spectrum between MedTech Technology providers and healthcare facilities and medical institutions. MedTech Outlook monitors and informs about MedTech trends, challenges, and solutions. MedTech Outlook assists purchasers/procurers, decision-makers, and heads of operations, healthcare managers from peer vetted authoritative contributions.

For more information:

Caitlin Cameron

Chair and Chief Executive Officer

OtoNexus Medical Technologies

caitlinc@otonexus.com

206-330-0610

OtoNexus Medical Technologies Otitis Media Middle Ear Infections (PRNewsfoto/OtoNexus Medical Technologies)
OtoNexus Medical Technologies Otitis Media Middle Ear Infections (PRNewsfoto/OtoNexus Medical Technologies)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/otonexus-medical-technologies-at-the-forefront-of-providing-infection-control-solution-301144502.html

SOURCE OtoNexus Medical Technologies